Brodalumab effective for rare, severe types of psoriasis

The investigational interleukin-17 inhibitor brodalumab was safe and effective in a small phase III Japanese study of adults with two rare and severe types of psoriasis, generalized pustular psoriasis (GPP) and psoriatic erythroderma (PsE). The results were published in the British Journal of...
Source: Skin and Allergy News - Category: Dermatology Source Type: news